Breaking News
Sort by:
Top Post
Johnson & Johnson Joins World Health Organization in Efforts to Prevent Spread of Ebola in West Africa
Johnson & Johnson (NYSE: JNJ) (the Company) today announced the World Health Organization (WHO) and […]
VXPASS Selected to Manage and Verify Digital Records for COVID-19 Vaccination Rollout for Kingdom of Lesotho
VXPASS, a blockchain-based platform built to manage, store and verify records for global COVID-19 vaccination […]
ViiV Healthcare New Drug Application for Long-Acting Cabotegravir for Prevention of HIV
ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer […]
Hancock: Modern Medicine May Cease to Exist Without Global AMR Action
Health and Social Care Secretary, Matt Hancock, will today call for urgent global action in […]
Huma and RARE-X Partner to Accelerate Research for 9,500 Rare Diseases
Huma, Europe’s fastest-growing health technology company, is partnering with the non-profit patient advocacy group RARE-X, which runs […]
Next Phase of Vaccine Roll-Out
The UK is moving into the next phase of the COVID-19 vaccine programme as the […]
Twice Weekly Rapid Testing to be Available to Everyone in England
Everyone in England will be able to access free, regular, rapid coronavirus testing from 9 […]
New UK Health Security Agency to lead response to future health threats
A new UK Health Security Agency (UKHSA) to plan for, prevent and respond to external […]
FDA statement on following the authorized dosing schedules for COVID-19 vaccines
Two different mRNA vaccines have now shown remarkable effectiveness of about 95% in preventing COVID-19 […]
Moderna announces FDA Authorization of Moderna COVID-19 vaccine in U.S.
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines today announced that […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more